Baxter International Inc. (BAX) Financials
BAX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 28.3 billion | 19.8 billion |
2023-09-30 | 30.7 billion | 22.5 billion |
2023-06-30 | 27.9 billion | 22.3 billion |
2023-03-31 | 28.3 billion | 22.4 billion |
BAX Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 341.0 million | 30.0 million |
2023-09-30 | 191.0 million | 41.0 million |
2023-06-30 | 195.0 million | 37.0 million |
2023-03-31 | 307.0 million | 25.0 million |
BAX Net Income
Date | Net Income |
---|---|
2023-12-31 | 73.0 million |
2023-09-30 | 51.0 million |
2023-06-30 | -238.0 million |
2023-03-31 | 45.0 million |
BAX Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 3.2 billion | - | 566.0 million |
2023-09-30 | 5.8 billion | 14.1 billion | 436.0 million |
2023-06-30 | 1.7 billion | 14.3 billion | 438.0 million |
2023-03-31 | 1.7 billion | 15.3 billion | 458.0 million |
BAX Shares Outstanding
BAX Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 190.0 million | 172.0 million | 935.0 million | - |
2023-09-30 | 174.0 million | 166.0 million | 1.0 billion | - |
2023-06-30 | 156.0 million | 165.0 million | 964.0 million | - |
2023-03-31 | 172.0 million | 164.0 million | 1.0 billion | - |
BAX Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 3.9 billion | 2.4 billion |
2023-09-30 | 3.7 billion | 2.6 billion |
2023-06-30 | 3.7 billion | 2.6 billion |
2023-03-31 | 3.6 billion | 2.3 billion |
BAX
List: Challengers
Price: $40.40
Dividend Yield: 0.03%
Forward Dividend Yield: 2.87%
Payout Ratio: -773.33%
Dividend Per Share: 1.16 USD
Earnings Per Share: -0.15 USD
P/E Ratio: -263.67
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 4.7 million
Ebitda: 283.0 millionMarket Capitalization: 21.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 43
DGR3: 9.74%
DGR5: 15.14%
DGR10: 6.04%
DGR20: 8.49%